small molecule therapeutics for septicemia/inflammation (Cell Biologics)

N/A

Report date: 2025/03/20 10:11:16
NME

Base Information

Drug Namesmall molecule therapeutics for septicemia/inflammation (Cell Biologics)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionE3 ubiquitin-protein ligase CBL-B modulators
TargetsE3 ubiquitin-protein ligase CBL-B
Therapy Area/IndicationsInflammationSepsis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCell Biologics Inc
China Registration ClassN/A

Develop Information

Active CompaniesCell Biologics Inc
Inactive CompaniesN/A
Active IndicationsInflammationSepsis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A